Bioanalytical Systems Inc (BASI):企業の財務・戦略的SWOT分析

◆英語タイトル:Bioanalytical Systems Inc (BASI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15069
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Bioanalytical Systems Inc (Bioanalytical Systems) is a contract research organization that provides drug discovery and development services, and analytical instruments. The company’s contract research services include screening and pharmacological testing, formulation development, preclinical safety testing, regulatory compliance and quality control testing. It also designs, develops, manufactures and markets in vivo sampling systems and accessories; physiology monitoring tools, used to monitor and diagnose cardiac function in cats and dogs in veterinary clinics; and liquid chromatography and electrochemistry instruments and accessories. The company serves pharmaceutical and biotechnology industries, and academic, non-profit and government organizations. It markets its products through a network of distributors in Japan, the Pacific Basin, South America, the Middle East, India, South Africa and Eastern Europe. Bioanalytical Systems is headquartered in West Lafayette, Indiana, the US.

Bioanalytical Systems Inc Key Recent Developments

Feb 21,2019: BASi appoints Joe Flynn as chief commercial officer
Feb 21,2019: BASi Appoints Joe Flynn as Chief Commercial Officer
Feb 15,2019: BASi Appoints Senior Contract Research Executive, D. Thomas Oakley, as Chief Operating Officer
Feb 15,2019: BASi names D. Thomas Oakley as Chief Operating Officer
Feb 14,2019: BASi reports revenue growth in first quarter of fiscal 2019

This comprehensive SWOT profile of Bioanalytical Systems Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Bioanalytical Systems Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Bioanalytical Systems Inc – Key Information
Bioanalytical Systems Inc – Overview
Bioanalytical Systems Inc – Key Employees
Bioanalytical Systems Inc – Key Employee Biographies
Bioanalytical Systems Inc – Key Operational Heads
Bioanalytical Systems Inc – Major Products and Services
Bioanalytical Systems Inc – History
Bioanalytical Systems Inc – Company Statement
Bioanalytical Systems Inc – Locations And Subsidiaries
Bioanalytical Systems Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Bioanalytical Systems Inc – Business Description
Bioanalytical Systems Inc – Corporate Strategy
Bioanalytical Systems Inc – SWOT Analysis
SWOT Analysis – Overview
Bioanalytical Systems Inc – Strengths
Bioanalytical Systems Inc – Weaknesses
Bioanalytical Systems Inc – Opportunities
Bioanalytical Systems Inc – Threats
Bioanalytical Systems Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Bioanalytical Systems Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Bioanalytical Systems Inc, Key Information
Bioanalytical Systems Inc, Key Ratios
Bioanalytical Systems Inc, Share Data
Bioanalytical Systems Inc, Major Products and Services
Bioanalytical Systems Inc, History
Bioanalytical Systems Inc, Key Employees
Bioanalytical Systems Inc, Key Employee Biographies
Bioanalytical Systems Inc, Key Operational Heads
Bioanalytical Systems Inc, Other Locations
Bioanalytical Systems Inc, Subsidiaries
Bioanalytical Systems Inc, Key Manufacturing facilities
Bioanalytical Systems Inc, Key Competitors
Bioanalytical Systems Inc, SWOT Analysis
Bioanalytical Systems Inc, Ratios based on current share price
Bioanalytical Systems Inc, Annual Ratios
Bioanalytical Systems Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Bioanalytical Systems Inc, Performance Chart
Bioanalytical Systems Inc, Ratio Charts

★海外企業調査レポート[Bioanalytical Systems Inc (BASI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pets at Home Group Plc:戦略・SWOT・企業財務分析
    Pets at Home Group Plc - Strategy, SWOT and Corporate Finance Report Summary Pets at Home Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Mattel, Inc (MAT):企業の財務・戦略的SWOT分析
    Mattel, Inc (MAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Air Liquide Welding France, S.A.:企業の戦略・SWOT・財務情報
    Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report Summary Air Liquide Welding France, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Teleflex Inc (TFX):企業の財務・戦略的SWOT分析
    Teleflex Inc (TFX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Medical Facilities Corp (DR):製薬・医療:M&Aディール及び事業提携情報
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • Innovent Biologics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that discovers, develops and manufactures monoclonal antibodies. The company offers monoclonal antibodies such as IBI301, IBI302 and IBI303, among others. Its products are used for the treatment of non-Hodgkin’s lymph …
  • Dongbu HiTek Co., Ltd. (000990):企業の財務・戦略的SWOT分析
    Dongbu HiTek Co., Ltd. (000990) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Adcock Ingram Holdings Ltd (AIP):企業の財務・戦略的SWOT分析
    Adcock Ingram Holdings Ltd (AIP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Sunstar Holding AG:戦略・SWOT・企業財務分析
    Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • WntResearch AB (WNT):製薬・医療:M&Aディール及び事業提携情報
    Summary WntResearch AB (WntResearch) is a biotechnology company that develops novel anti-metastatic therapies for the treatment of cancer. The company's development stage products include Foxy-5 and Box-5. Its lead project, Foxy-5, a peptide which is in Phase I clinical development for reconstitutin …
  • Sevion Therapeutics Inc (SVON)-製薬・医療分野:企業M&A・提携分析
    Summary Sevion Therapeutics Inc (Sevion), formerly Senesco Technologies, Inc. is a pharmaceutical company that discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company has developed protein nanocage system that allows delivery of nucleic …
  • QPS Holdings LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary QPS Holdings LLC (QPS) is a contract research organization that offers bioanalytical contract services. The organization’s services include neuropharmacology, toxicology, DMPK, bioanalysis, translational medicine, clinical development, clinical research, and dermal and transdermal research s …
  • Selvita SA (SLV):製薬・医療:M&Aディール及び事業提携情報
    Summary Selvita SA (Selvita) is a drug discovery company that focuses on the research and development of cancer therapies. The company develops novel small molecule drugs, and markets them with partners from the pharmaceutical industry. Its products find application in the therapeutic areas of oncol …
  • Dairy Farm International Holdings Limited:戦略・SWOT・企業財務分析
    Dairy Farm International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Dairy Farm International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Horizon Pharma Plc (HZNP):製薬・医療:M&Aディール及び事業提携情報
    Summary Horizon Pharma plc (Horizon Pharma) is a pharmaceutical company which develops and commercializes medical products for the treatment of pain, arthritis and inflammatory diseases. It markets medicines through its orphan, primary care and rheumatology business units. The company’s marketed pro …
  • Commerce Resources Corp (CCE):企業の財務・戦略的SWOT分析
    Summary Commerce Resources Corp (Commerce Resources) is a minerals exploration and development company that explores for deposits of rare earth elements and rare metals. The company acquires, explores, produces, develops, evaluates mineral resource properties, and others. It explores for niobium and …
  • Hermes International SA:企業の戦略・SWOT・財務情報
    Hermes International SA - Strategy, SWOT and Corporate Finance Report Summary Hermes International SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • HUP-Zagreb d.d.:企業の戦略・SWOT・財務情報
    HUP-Zagreb d.d. - Strategy, SWOT and Corporate Finance Report Summary HUP-Zagreb d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Krka dd Novo Mesto (KRKG):企業の財務・戦略的SWOT分析
    Summary Krka dd Novo Mesto (Krka) is a manufacturer and distributor of pharmaceutical products. The company provides prescription pharmaceuticals, non-prescription products, and animal health products. It offers prescription products for cardiovascular diseases, diseases of alimentary tract and meta …
  • Fondazione Telethon:製薬・医療:M&Aディール及び事業提携情報
    Summary Fondazione Telethon (Telethon) is a non-profit healthcare organization that funds and invests for projects in the area of biomedical research on genetic diseases. The organization develops projects by offering support services for increasing the horizons of therapeutic application to new res …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆